# Marc Tischkowitz

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/marc-tischkowitz/

## Facts

| Field | Value |
| --- | --- |
| Citations | 35,791 |
| Field | BRCA gene mutations in cancer |
| h-index | 90 |
| i10-index | 281 |
| Last Known Institution | University of Cambridge |
| OpenAlex ID | https://openalex.org/A5053665832 |
| ORCID iD | https://orcid.org/0000-0002-7880-0628 |
| Works | 507 |

## Researcher papers

- [Risks of Breast, Ovarian, and Contralateral Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers](https://scholariq.org/papers/risks-of-breast-ovarian-and-contralateral-breast-cancer-for-i-brca1-i-and-i/)
- [BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors](https://scholariq.org/papers/boadicea-a-comprehensive-breast-cancer-risk-prediction-model-incorporating/)
- [Evidence for 28 genetic disorders discovered by combining healthcare and research data](https://scholariq.org/papers/evidence-for-28-genetic-disorders-discovered-by-combining-healthcare-and/)
- [Personalized early detection and prevention of breast cancer: ENVISION consensus statement](https://scholariq.org/papers/personalized-early-detection-and-prevention-of-breast-cancer-envision-consensus/)
- [Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk](https://scholariq.org/papers/genome-wide-association-study-in-brca1-mutation-carriers-identifies-novel-loci/)
- [Identification of six new susceptibility loci for invasive epithelial ovarian cancer](https://scholariq.org/papers/identification-of-six-new-susceptibility-loci-for-invasive-epithelial-ovarian/)
- [Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study](https://scholariq.org/papers/targeted-prostate-cancer-screening-in-brca1-and-brca2-mutation-carriers-results/)
- [Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers](https://scholariq.org/papers/interim-results-from-the-impact-study-evidence-for-prostate-specific-antigen/)
- [<i>PALB2</i>, <i>CHEK2</i> and <i>ATM</i> rare variants and cancer risk: data from COGS](https://scholariq.org/papers/i-palb2-i-i-chek2-i-and-i-atm-i-rare-variants-and-cancer-risk-data-from-cogs/)
- [Prediction of Breast and Prostate Cancer Risks in Male <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers Using Polygenic Risk Scores](https://scholariq.org/papers/prediction-of-breast-and-prostate-cancer-risks-in-male-i-brca1-i-and-i-brca2-i/)

## Researcher topics

- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)
- [DNA Repair Mechanisms](https://scholariq.org/topics/dna-repair-mechanisms/)
- [Genetic factors in colorectal cancer](https://scholariq.org/topics/genetic-factors-in-colorectal-cancer/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)

## Researcher university

- [University of Cambridge](https://scholariq.org/institutions/university-of-cambridge/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.